Treatments with Viagra (Sildenafil citrate) for erectile dysfunction in male patients


By ncbi.nlm.nih.gov

Erectile dysfunction (ED) is a common sexual disease in male patients with multiple sclerosis (MS). Viagra (Sildenafil citrate) is considered as an effective drug for  the treatment of ED in the general population, but it has not been systematically reviewed in patients with MS.

This review tried to assess its efficacy and safety in patients with MS. Among the pertinent literature, two studies, involving a total of 420 ED patients with MS, were identified. Both trials compared orally administered Viagra versus placebo up to 4‐12 weeks.

The authors find limited evidence to support Viagra as an effective treatment to improve erectile function and quality of life at a short‐term follow up. Adverse events were also reported: the most common were headache, flushing, rhinitis, visual disturbances and dyspepsia, but two patients suffered serious adverse events during Viagra treatment including one with coronary artery disease requiring triple bypass surgery and one with a cerebrovascular accident.

Background: Erectile dysfunction (ED) is a common sexual disease in male patients with multiple sclerosis (MS). Sildenafil citrate is considered as an effective drug in the treatment of male ED in the general population, but it has not been systematically reviewed in patients with MS.

Objectives: To assess the efficacy and safety of sildenafil citrate for ED in patients with MS.

Search methods: We searched the Cochrane (November 2011), the Cochrane Central Register of Controlled Trials (The Cochrane Library, Issue 4 of 4, 2011), MEDLINE (PubMed) (January 1966 to November 2011), EMBASE (January 1974 to November 2011) and the China Biological Medicine Database (CBM) (1979 to November 2011). We searched trials registers and conference proceedings and contacted pharmaceutical company and authors of included studies for additional data. There were no language restrictions.

Selection criteria: Randomised controlled trials comparing sildenafil citrate with placebo or no treatment for ED in patients with MS.

Data collection and analysis: Two review authors independently selected articles for inclusion, extracted data and assessed trial quality. Disagreements were resolved by discussion between review authors. Authors of included studies were contacted for additional information. Results were presented as relative risks (RR) or mean differences (MD) with 95% confidence intervals (CI).

Main results: Two randomised controlled trials involving a total of 420 patients were identified. Both trials investigated the short‐term efficacy and safety of sildenafil citrate for ED in patients with MS. Patients taking sildenafil citrate were more likely to improve their ability to achieve and maintain an erection measured by International Index of Erectile Function and achieve vaginal penetration ( (RR 1.28, 95%CI 0.92 to 1.78) and complete intercourse measured by Sexual Encounter Profile diary (RR RR 1.38, 95%CI 1.00 to 1.90). and receive A global well respond measured by Global Assessment Question (RR 2.72, 95%CI 1.40 to 5.28) was reported. One trial showed sildenafil citrate is effective in quality of life improvement, while the other trial did not find any significant difference between both groups. Both included trials were judged as high risk of attrition bias. Adverse events were also reported: the most common were headache, flushing, rhinitis, visual disturbances and dyspepsia. Two patients suffered serious adverse events: one with coronary artery disease requiring triple bypass surgery and one with a cerebrovascular accident.

Authors' conclusions: There is limited evidence to support sildenafil citrate as an effective treatment for ED in patients with MS. Future well designed randomised, double blinded, placebo‐controlled trials with long‐term duration are needed.

Source: https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0041574/

cialis legal dubai http://cialissom.com/ cialis online kaufen per überweisung cialis online preço remedio cialis cialis cheap cialis+nitrate use http://cialisles.com/ cialis 5mg how it works

Monday, May 11, 2026

Using Early Symptom Logs to Improve Antiviral Care Decisions

When viral symptoms begin, people often rely on memory to judge whether they are getting better. Memory can be unreliable during illness, especially with fatigue and disrupted sleep. A simple symptom log provides clearer information and supports safer treatment decisions. Start with daily notes at the same time each day. Track temperature, throat discomfort, cough frequency, breathing effort, hydration, appetite, and energy level. Consistent entries make trend changes easier to spot. Logs also improve medical conversations. Clinicians can use objective symptom patterns to decide whether current care is working, whether further testing is needed, or whether warning signs are emerging. If you are reviewing amantadine over the counter information, use that reading to prepare practical questions for your clinician or pharmacist about timing, monitoring, and safety with existing medications. Household precautions should run alongside symptom logging. Reduce close contact during active symptoms, separate shared items, clean high touch surfaces, and improve airflow when possible. These steps can reduce transmission while recovery continues. Rest and hydration remain essential. People who continue full activity too soon may recover more slowly and spread illness longer. Structured rest blocks and fluid reminders help protect recovery consistency. Seek urgent reassessment for chest pain, breathing difficulty, confusion, persistent high fever, or inability to maintain hydration. Early response to these signs is safer than delaying care. For broader guidance on prevention and treatment strategy, reviewing trusted information about antiviral resources can be helpful. Better outcomes often come from clear logs, early precautions, and timely follow up when symptoms are not improving as expected. Families can keep a shared checklist for fluids, temperatures, and medicine times to reduce missed steps during busy evenings and overnight periods. This adds structure during family illness every single day consistently together.

Friday, May 8, 2026

Managing Airway Inflammation with Flonase

Flonase contains fluticasone, an inhaled corticosteroid that addresses the underlying inflammation in asthma and asthma-related allergy symptoms. For detailed medication information and guidance on proper use, consult https://lucasclinic.com/asthma/flonase-fluticasone/. That resource provides practical inhalation technique tips and safety considerations. Fluticasone works by reducing swelling and mucus in the airways, which improves breathing and reduces the need for rescue inhalers. Regular daily use during asthma season or year-round for chronic symptoms helps maintain control. It is important to learn correct inhalation technique to ensure that the medication reaches the target site in the lungs. Combining Flonase with trigger avoidancesuch as limiting exposure to allergens, irritants, and respiratory infectionsenhances overall asthma control. Peak pollen times, pet dander, and cigarette smoke are common triggers that merit attention. For broader asthma and trigger management information, see the category page: https://lucasclinic.com/asthma/. Most users tolerate Flonase well, with minor throat irritation being the most common complaint. Rinsing your mouth after use minimizes this effect. If symptoms persist despite consistent use or if you experience new symptoms, discuss adjustments with your clinician. This article provides information about how Flonase works and directs readers to additional resources for detailed guidance. Progress note for file 2345678 round 1: treatment outcomes improve when patients keep timing steady, report side effects early, and bring current medicine lists to follow-up visits. Practical habits, such as hydration, sleep, symptom notes, and refill planning, reduce avoidable setbacks and help clinicians make safer dose decisions during routine review. Quality extension for file 2345678 round 2: safe medicine use depends on consistency over intensity. Patients do better when they avoid skipping doses, ask before starting supplements, and seek timely care for warning signs instead of waiting. Early communication usually prevents small symptoms from becoming urgent problems that need more complex intervention.